Plasma Cytokines Profile in Patients with Parkinson’s Disease Associated with Mutations in GBA Gene

Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson’s disease

(2018) M.N. Karpenko et al.   CELLULAR IMMUNOLOGY

A low blood copper concentration is a co-morbidity burden factor in Parkinson’s disease development

(2017) Ekaterina Y. Ilyechova et al.   NEUROSCIENCE RESEARCH

The clinical features of Parkinson’s disease in patients with mutations and polymorphic variants of GBA gene

(2017) K. A. Senkevich et al.   Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Brain Injection of  -Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker

(2014) A. N. Sacino et al.   JOURNAL OF NEUROSCIENCE

Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease

(2013) Shyra J. Gardai et al.   PLoS One

Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs WithoutGBAMutations

(2013) Lama M. Chahine et al.   JAMA Neurology

Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients

(2012) Dariusz Koziorowski et al.   CYTOKINE

The link between the GBA gene and parkinsonism

(2012) Ellen Sidransky et al.   LANCET NEUROLOGY